Company Profiles

driven by the PitchBook Platform

Oxyrane

Description

Developer of yeast organisms in the fields of chiral chemistry and biocatalysis. The company develops therapeutic proteins for Lysosomal storage disorders.

2006

Founded

PRIVATE

Status

Series E

Latest Deal Type

$29.9M

Latest Deal Amount

$61.3M

Total Amount Raised

2

Investors

Description

Developer of yeast organisms in the fields of chiral chemistry and biocatalysis. The company develops therapeutic proteins for Lysosomal storage disorders.

Website:

www.oxyrane.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Biotechnology
Drug Discovery

Primary Office

Suite 313, Piccadilly House 49 Piccadilly Manchester M1 2APEngland +44 (0)16 1232 6000
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Oxyrane's full profile, request a free trial.

    Oxyrane Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Oxyrane Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Oxyrane Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Forbion Capital PartnersVenture CapitalMinority000 0000000 0000
    New Science VenturesVenture CapitalMinority000 0000000 0000
    Forbion Capital Partners Venture Capital
    New Science Ventures Venture Capital

    Oxyrane Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Evert KüppersChief Executive Officer & Board Member
    Wouter Vervecken Ph.DChief Technology Officer
    Taennler SimonHead, Fermentation
    Evert Küppers Chief Executive Officer & Board Member
    Wouter Vervecken Ph.D Chief Technology Officer
    Taennler Simon Head, Fermentation

    Oxyrane Board Members (9)

    NameRepresentingRoleSinceContact
    Info
    Charlie Richard Ph.DOxyraneBoard Member000 0000
    Christopher BullSelfDirector000 0000
    Evert KüppersOxyraneChief Executive Officer & Board Member000 0000
    Gerald Chan Ph.DMorningside GroupDirector000 0000
    Marco Boorsma Ph.DForbion Capital PartnersBoard Observer000 0000
    Charlie Richard Ph.D Board Member Oxyrane
    Christopher Bull Director Self
    Evert Küppers Chief Executive Officer & Board Member Oxyrane
    Gerald Chan Ph.D Director Morningside Group
    Marco Boorsma Ph.D Board Observer Forbion Capital Partners
    Request full access to PitchBook